High-dose IgG treatment for neonatal alloimmune thrombocytopenia
- 1 July 1989
- journal article
- Published by Springer Nature in Annals of Hematology
- Vol. 59 (1) , 145-146
- https://doi.org/10.1007/bf00320268
Abstract
Twelve children with neonatal alloimmune thrombocytopenia (NAT) due to Zwa incompatibility were treated with intravenous IgG (IVIG). Total doses ranged between 1 and 9 g. Ten out of 12 infants had a favorable response. It is concluded that IVIG can serve as an emergency treatment in NAT if material (or compatible) platelets are not available.Keywords
This publication has 12 references indexed in Scilit:
- 348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1989
- PRENATAL TREATMENT OF FETAL ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1988
- High-dose IgG for post-transfusion purpura-revisitedAnnals of Hematology, 1988
- Failure of Antenatal High‐Dose Immunoglobulin to Improve Fetal Platelet Count in Neonatal Allo‐Immune ThrombocytopeniaVox Sanguinis, 1988
- High‐dose intravenous gammaglobulin (IVG) in neonatal immune thrombocytopeniaAmerican Journal of Hematology, 1987
- Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopeniaThe Journal of Pediatrics, 1987
- Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia.Archives of Disease in Childhood, 1985
- The treatment of neonatal isoimmune thrombocytopenia with intravenous immunoglobin (IgG i.v.)Annals of Hematology, 1984
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981
- Use of Compatible Platelet Transfusions in Treatment of Congenital Isoimmune Thrombocytopenic PurpuraNew England Journal of Medicine, 1969